Citi Starts Bellicum Pharmaceuticals (BLCM) at Buy
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Price: $0.62 --0%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Join SI Premium – FREE
Citi initiated coverage on Bellicum Pharmaceuticals (NASDAQ: BLCM) with a Buy rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Bellicum Pharmaceuticals click here. For more ratings news on Bellicum Pharmaceuticals click here.
Shares of Bellicum Pharmaceuticals closed at $18.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts TJX Companies rating to Neutral, lowers price target
- Jefferies Starts Faraday Copper Corp (FDY:CN) (CPPKF) at Buy
- Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
